NCT00111228 The Guardcontrol Trial: Study to Assess if Type 1 Diabetics Can Improve Using the Real-time Values of Guardian RT Status COMPLETED Phase NA
NCT00108524 A Low-Carbohydrate, Ketogenic Diet Versus Orlistat for Weight Loss Status COMPLETED Phase NA
NCT00106457 20 Year Changes in Fitness & Cardiovascular Disease Risk - Ancillary to CARDIA Status COMPLETED Phase N/A
NCT00106236 Efficacy of Exercise at a Fitness Club for Cardiovascular Risk Reduction Status COMPLETED Phase PHASE1/PHASE2
NCT00105755 Dermal Thermometry and Self-Care of High Risk Diabetic Patients Status COMPLETED Phase NA
NCT00102297 Study of the Safety of FG-3019 in Incipient Nephropathy Due to Type 1 or Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE1
NCT00101478 Improving Cardiovascular Treatment Approaches Among Minorities Status COMPLETED Phase N/A
NCT00099151 CALERIE (PBRC, Baton Rouge) - Comprehensive Assessment of Long-Term Effects of Reducing Intake of Energy Status COMPLETED Phase NA
NCT00093015 Trial to Reduce Cardiovascular Events With Aranesp® Therapy (TREAT) Status COMPLETED Phase PHASE3
NCT00089557 An Open-Label Extension Study of NGX-4010 for the Treatment of Neuropathic Pain Status TERMINATED Phase PHASE2
NCT00086450 Comparison of Two Treatments for Multivessel Coronary Artery Disease in Individuals With Diabetes (FREEDOM) Status UNKNOWN Phase PHASE3
NCT00084110 Use of Complementary and Alternative Medicine Among Older Mexican Americans Status TERMINATED Phase N/A
NCT00082316 Tolerability of Three Local Anesthetic Formulations in Conjunction With NGX-4010 for the Treatment of Neuropathic Pain Status COMPLETED Phase PHASE2
NCT00082238 Increased Gluconeogenesis is One Cause of Cystic Fibrosis Related Diabetes (CFRD) Status COMPLETED Phase NA